The PKC agonist bryostatjn 1 stimulates developmental hematopoies1s in embryonic stem (ES) cells

G. D. Kalma, O. M. Smith, Nicole R Murray, B. Carr, A. Field, W. S. May

Research output: Contribution to journalArticle

Abstract

We previously discovered that the natural product byrostatm (bryo), a potent acm ator of protein kmaseC (PKC), stimulates the protifcraiion of both adult human and mouse hematopoietic cells. To study the effects of bryo on developmental hcmatopoiesis. we examined the proliferat-ve potential and lineage commitment of munne ES cells in a twostep culture system. ES cells (6000/mI) were deprived of LIF factor and incubated with various concentrations of bryo( 10-10 I3M) in primary (1 ) methyîcellulose cultures for 6 days to form embryoid bodies <EB) EB were disrupted and IxlO5 cells/ml were plated in secondary (2C) methylccllulose cultures with or without bryo m the presence of purified munnc hematopoietic growth factors (SCF, IL- la, IL-3, GM-CSF) and EPÖ for another 7 days Results showed that when 10 M bryo was present in either the I:> or both 1!1 and 2 cultures, a significant increase m the BFU-c from 6± 2.2 to 16 3 3 1, CFU-GEMM from 5.5 ±I 9 to 24.3 ±4 6 andCFU-GM from 57 8 ±10.9 to 146.3 ±25 3 colonies was observed, indicating 3 stimulation of both early multipotential and lineage restricted colonies Interestingly, it was only necessary to add bryo in the 1 ' cultures to observe enhanced colony stimulation, indicating a potential requirement for stimulation of PKC during the early developmental stages injvitES- To determine which PKC isoforms may be activated, ES cells were screened for expression using isoform specific antibodies Results demonstrate that PKCcc. 0 and e were down regulated, while pi, C/i were not affected by bryo and βll and v isoforms were not expressed in ES cells. Collectively, these data indicate that ES cells are developmcntally sensitive to bryo during m vitro hematopoiesis and specific PKC isoforms may represent the targets) for the agonist. Thus, bryo represents a useful agent for studying the molecular/biochemical signaling during developmental hematopoiesis.

Original languageEnglish (US)
Pages (from-to)1028
Number of pages1
JournalExperimental Hematology
Volume24
Issue number9
StatePublished - 1996
Externally publishedYes

Fingerprint

Embryonic Stem Cells
Protein Isoforms
Hematopoiesis
Proteins
Embryoid Bodies
Myeloid Progenitor Cells
Biological Products
Antibodies

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

The PKC agonist bryostatjn 1 stimulates developmental hematopoies1s in embryonic stem (ES) cells. / Kalma, G. D.; Smith, O. M.; Murray, Nicole R; Carr, B.; Field, A.; May, W. S.

In: Experimental Hematology, Vol. 24, No. 9, 1996, p. 1028.

Research output: Contribution to journalArticle

Kalma, G. D. ; Smith, O. M. ; Murray, Nicole R ; Carr, B. ; Field, A. ; May, W. S. / The PKC agonist bryostatjn 1 stimulates developmental hematopoies1s in embryonic stem (ES) cells. In: Experimental Hematology. 1996 ; Vol. 24, No. 9. pp. 1028.
@article{591e454da6ce41e1823239623c93b5b4,
title = "The PKC agonist bryostatjn 1 stimulates developmental hematopoies1s in embryonic stem (ES) cells",
abstract = "We previously discovered that the natural product byrostatm (bryo), a potent acm ator of protein kmaseC (PKC), stimulates the protifcraiion of both adult human and mouse hematopoietic cells. To study the effects of bryo on developmental hcmatopoiesis. we examined the proliferat-ve potential and lineage commitment of munne ES cells in a twostep culture system. ES cells (6000/mI) were deprived of LIF factor and incubated with various concentrations of bryo( 10-10 I3M) in primary (1 ) methy{\^i}cellulose cultures for 6 days to form embryoid bodies <EB) EB were disrupted and IxlO5 cells/ml were plated in secondary (2C) methylccllulose cultures with or without bryo m the presence of purified munnc hematopoietic growth factors (SCF, IL- la, IL-3, GM-CSF) and EP{\"O} for another 7 days Results showed that when 10 M bryo was present in either the I:> or both 1!1 and 2 cultures, a significant increase m the BFU-c from 6± 2.2 to 16 3 3 1, CFU-GEMM from 5.5 ±I 9 to 24.3 ±4 6 andCFU-GM from 57 8 ±10.9 to 146.3 ±25 3 colonies was observed, indicating 3 stimulation of both early multipotential and lineage restricted colonies Interestingly, it was only necessary to add bryo in the 1 ' cultures to observe enhanced colony stimulation, indicating a potential requirement for stimulation of PKC during the early developmental stages injvitES- To determine which PKC isoforms may be activated, ES cells were screened for expression using isoform specific antibodies Results demonstrate that PKCcc. 0 and e were down regulated, while pi, C/i were not affected by bryo and βll and v isoforms were not expressed in ES cells. Collectively, these data indicate that ES cells are developmcntally sensitive to bryo during m vitro hematopoiesis and specific PKC isoforms may represent the targets) for the agonist. Thus, bryo represents a useful agent for studying the molecular/biochemical signaling during developmental hematopoiesis.",
author = "Kalma, {G. D.} and Smith, {O. M.} and Murray, {Nicole R} and B. Carr and A. Field and May, {W. S.}",
year = "1996",
language = "English (US)",
volume = "24",
pages = "1028",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - The PKC agonist bryostatjn 1 stimulates developmental hematopoies1s in embryonic stem (ES) cells

AU - Kalma, G. D.

AU - Smith, O. M.

AU - Murray, Nicole R

AU - Carr, B.

AU - Field, A.

AU - May, W. S.

PY - 1996

Y1 - 1996

N2 - We previously discovered that the natural product byrostatm (bryo), a potent acm ator of protein kmaseC (PKC), stimulates the protifcraiion of both adult human and mouse hematopoietic cells. To study the effects of bryo on developmental hcmatopoiesis. we examined the proliferat-ve potential and lineage commitment of munne ES cells in a twostep culture system. ES cells (6000/mI) were deprived of LIF factor and incubated with various concentrations of bryo( 10-10 I3M) in primary (1 ) methyîcellulose cultures for 6 days to form embryoid bodies <EB) EB were disrupted and IxlO5 cells/ml were plated in secondary (2C) methylccllulose cultures with or without bryo m the presence of purified munnc hematopoietic growth factors (SCF, IL- la, IL-3, GM-CSF) and EPÖ for another 7 days Results showed that when 10 M bryo was present in either the I:> or both 1!1 and 2 cultures, a significant increase m the BFU-c from 6± 2.2 to 16 3 3 1, CFU-GEMM from 5.5 ±I 9 to 24.3 ±4 6 andCFU-GM from 57 8 ±10.9 to 146.3 ±25 3 colonies was observed, indicating 3 stimulation of both early multipotential and lineage restricted colonies Interestingly, it was only necessary to add bryo in the 1 ' cultures to observe enhanced colony stimulation, indicating a potential requirement for stimulation of PKC during the early developmental stages injvitES- To determine which PKC isoforms may be activated, ES cells were screened for expression using isoform specific antibodies Results demonstrate that PKCcc. 0 and e were down regulated, while pi, C/i were not affected by bryo and βll and v isoforms were not expressed in ES cells. Collectively, these data indicate that ES cells are developmcntally sensitive to bryo during m vitro hematopoiesis and specific PKC isoforms may represent the targets) for the agonist. Thus, bryo represents a useful agent for studying the molecular/biochemical signaling during developmental hematopoiesis.

AB - We previously discovered that the natural product byrostatm (bryo), a potent acm ator of protein kmaseC (PKC), stimulates the protifcraiion of both adult human and mouse hematopoietic cells. To study the effects of bryo on developmental hcmatopoiesis. we examined the proliferat-ve potential and lineage commitment of munne ES cells in a twostep culture system. ES cells (6000/mI) were deprived of LIF factor and incubated with various concentrations of bryo( 10-10 I3M) in primary (1 ) methyîcellulose cultures for 6 days to form embryoid bodies <EB) EB were disrupted and IxlO5 cells/ml were plated in secondary (2C) methylccllulose cultures with or without bryo m the presence of purified munnc hematopoietic growth factors (SCF, IL- la, IL-3, GM-CSF) and EPÖ for another 7 days Results showed that when 10 M bryo was present in either the I:> or both 1!1 and 2 cultures, a significant increase m the BFU-c from 6± 2.2 to 16 3 3 1, CFU-GEMM from 5.5 ±I 9 to 24.3 ±4 6 andCFU-GM from 57 8 ±10.9 to 146.3 ±25 3 colonies was observed, indicating 3 stimulation of both early multipotential and lineage restricted colonies Interestingly, it was only necessary to add bryo in the 1 ' cultures to observe enhanced colony stimulation, indicating a potential requirement for stimulation of PKC during the early developmental stages injvitES- To determine which PKC isoforms may be activated, ES cells were screened for expression using isoform specific antibodies Results demonstrate that PKCcc. 0 and e were down regulated, while pi, C/i were not affected by bryo and βll and v isoforms were not expressed in ES cells. Collectively, these data indicate that ES cells are developmcntally sensitive to bryo during m vitro hematopoiesis and specific PKC isoforms may represent the targets) for the agonist. Thus, bryo represents a useful agent for studying the molecular/biochemical signaling during developmental hematopoiesis.

UR - http://www.scopus.com/inward/record.url?scp=33748588125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748588125&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 1028

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 9

ER -